Crescent Park Management, L.P. - Jul 13, 2021 Form 4 Insider Report for Genesis Park Acquisition Corp. (RDW)

Role
10%+ Owner
Signature
Doug Edwards, Chief Financial Officer of Crescent Park Management, L.P.
Stock symbol
RDW
Transactions as of
Jul 13, 2021
Transactions value $
$228,655
Form type
4
Date filed
7/15/2021, 05:37 PM
Previous filing
Jun 4, 2021
Next filing
Sep 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RDW Class A Ordinary Shares Purchase $200K +19.4K +0.76% $10.32 2.57M Jul 13, 2021 See Notes 1 and 2 F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RDW Warrant Purchase $28.6K +9.7K +0.76% $2.94 1.29M Jul 13, 2021 Class A Ordinary Shares 9.7K $11.50 See Notes 1 and 2 F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting persons are Crescent Park Management, L.P. ("Crescent Park"), Crescent Park GP, LLC ("Crescent Park GP") and Eli D. Cohen. Crescent Park is the investment adviser of investment funds (the "Funds"), and Crescent Park GP is the general partner of the Funds. Mr. Cohen is the control person of Crescent Park and Crescent Park GP. Crescent Park is filing this report for itself and the other reporting persons. The reporting persons are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934.
F2 The Funds hold the securities reported herein directly for the benefit of their investors. Crescent Park and Crescent Park GP indirectly beneficially own the securities reported herein as the investment adviser and general partner, respectively, of the Funds. Mr. Cohen indirectly beneficially owns the securities reported herein as the control person of Crescent Park and Crescent Park GP. The reporting persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest in them.
F3 The warrants will become exercisable on the later of 30 days after the completion of the Issuer's initial business combination and November 27, 2021.
F4 The warrants will expire five years after the completion of the Issuer's initial business combination or earlier upon redemption of the warrants or liquidation of the Issuer.